GRPR and neoplasm: The emergence of heterodimeric peptides as novel targeting ligands for tumour imaging and therapy is supported by their potential enhanced binding affinity, improved specificity and improved pharmacokinetic properties.[32] Therefore, in this work we were interested in developing a small series of radiolabeled heterodimers for dual targeting of NTS1 and GRPR.